Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Piperazine, hexahydrate | HCID 120181 | — |
| Reactant | 7-Chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | HCID 483169 | — |
| Solvent | Water | HCID 962 | — |
| Product | Norfloxacin | HCID 4539 | — |
Reaction Steps
A mixture of 1-ethyl-6-fluoro-7-chloro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (1.9 g), piperazine hexahydrate (15 g) and water (15 ml) was heated at 170° C. in a sealed tube for 16 hours. After evaporation of the solvent, the residue was acidified with diluted hydrochloric acid, heated at 100° C., and the hot solution was filtered. The filtrate was evaporated to dryness. The residue was dissolved in 10% sodium hydroxide and neutralized with acetic acid. The precipitate was collected, washed with water, dried, and recrystallized from ethanol to give 1-ethyl-6-fluoro-1,4-dihydro-7-(1-piperazinyl)-4-oxoquinoline-3-carboxylic acid as colorless powder.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04448962 |
|---|
| Source dataset | uspto-grants-1984_05 |
|---|
| ORD ID | ord-c0013df55c8e4acd86c4c9cfa3148f97 |
|---|
| Source note | uspto-grants-1984_05 |
|---|